“…Drug delivery systems based on nanotechnology have been investigated to see whether they can circumvent these drawbacks [ [45] , [46] , [47] , [48] , [49] , [50] , [51] , [52] , [53] , [54] ]. Nanostructured drug delivery devices have superior physicochemical and biological features to their microscale counterparts [ [38] , [39] , [40] , [41] , [42] ]. Optically, the former systems are superior; their surface areas, conductivities, and interactions with biological molecules are enhanced ( Fig.…”